Clinical Trial Update: A Study of BL-M07D1 Combination Therapy in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BL-M07D1 in combination therapy for unresectable locally advanced or metastatic HER2-positive gastric or gastroesophageal junc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• BL-M07D1

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: RECRUITING